SciClone Pharmaceuticals

SciClone Pharmaceuticals is a specialty pharmaceutical company engaged in the development and commercialization of therapies primarily for oncology, infectious diseases, and cardiovascular disorders. Headquartered in Foster City, California, the company’s lead product, ZADAXIN, is utilized for treating hepatitis B and C, certain cancers, and as an immune system enhancer, with ongoing development aimed at addressing sepsis. In addition to ZADAXIN, SciClone markets various products, including DC Bead, which is approved for liver cancer treatment in multiple countries, and ondansetron RapidFilm for managing nausea and vomiting related to cancer therapies. The company has established strategic partnerships to promote products like Angiomax and Cleviprex. With a focus on addressing unmet medical needs, particularly in the rapidly growing markets of China, SciClone Pharmaceuticals continues to expand its portfolio and enhance its global presence.